A. Reichle

Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial

Christoph Röllig, Hubert Serve, Andreas Hüttmann et al. · The Lancet Oncology · 2015 · 400 citations · Full text

Medicine, Hematology, Oncology +6

Once-daily versus thrice-daily dosing of netilmicin in combination with β-lactam antibiotics as empirical therapy for febrile neutropenic patients

Eva Rozdzinski, Wolfgang Kern, A. Reichle et al. · Journal of Antimicrobial Chemotherapy · 1993 · 68 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

Increasing intensity of therapies assigned at diagnosis does not improve survival of adults with acute myeloid leukemia

Utz Krug, Wolfgang E. Berdel, Robert Peter Gale et al. · Leukemia · 2016 · 54 citations

Medicine, Oncology, Hematologic Oncology +3

The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group.

Carsten Bokemeyer, A. Harstrick, J. Beyer et al. · PubMed · 1998 · 47 citations

Medicine, Oncology, Chemotherapy +11

Clinical experience with posaconazole prophylaxis – a retrospective analysis in a haematological unit

J. Hahn, F. Stifel, A. Reichle et al. · Mycoses · 2010 · 36 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +16